Occult hepatitis B virus infection in dialysis patients: A multicentre survey

F. Fabrizi, P. G. Messa, G. Lunghi, F. Aucella, S. Bisegna, S. Mangano, M. Villa, F. Barbisoni, E. Rusconi, P. Martin

Research output: Contribution to journalArticle

58 Scopus citations

Abstract

Background: The epidemiology and clinical significance of occult hepatitis B virus infection (serum hepatitis B surface antigen-negative patients with detectable hepatitis B virus viraemia in serum) remains controversial with only limited information about its prevalence in patients on long-term dialysis. Aim: To address the epidemiology of occult HBV infection in a large cohort of dialysis patients. Methods: We screened a large cohort (n = 585) of Italian chronic dialysis patients; from this population, a group of hepatitis B virus surface antigen seronegative patients (n = 213) was tested by Amplicor hepatitis B virus Monitor Test to detect hepatitis B virus viraemia (hepatitis B virus-DNA) in serum. Results: Occult hepatitis B virus infection was absent (zero of 213 = 0%). Persistent hepatitis B virus surface antigen carriage was less frequent than anti-hepatitis B virus core antibody (anti-hepatitis B core antigen) seropositive status in this study group [1.88% (11 of 585) vs. 36% (216 of 585), P = 0.0001]. No dialysis patients seropositive for anti-hepatitis B core antibody in serum (zero of 123 = 0%) had detectable hepatitis B virus-DNA by polymerase chain reaction technology. No significant association between abnormal biochemical liver tests and serum anti-hepatitis B core antibody was noted in our population. Nominal logistic regression analysis demonstrated an independent and significant relationship between anti-HCV antibody and anti-hepatitis B virus core antibody in serum (Wald chi-square 16.06, P = 0.0001). The rate of seropositive patients for anti-hepatitis B virus core antibody was higher among study patients than controls with normal renal function [36.9% (216 of 585) vs. 21.4% (59 of 275), P = 0.0001]; this difference partially persisted after correction for demographic parameters, and viral markers. Conclusion: In conclusion, occult hepatitis B virus was absent in our study group. Anti-hepatitis B core antibody was significantly related to presence of anti-HCV antibody supporting shared modes of transmission. Clinical studies based on molecular biology techniques provided with higher sensitivity are planned.

Original languageEnglish (US)
Pages (from-to)1341-1347
Number of pages7
JournalAlimentary Pharmacology and Therapeutics
Volume21
Issue number11
DOIs
StatePublished - Jun 1 2005
Externally publishedYes

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Occult hepatitis B virus infection in dialysis patients: A multicentre survey'. Together they form a unique fingerprint.

  • Cite this

    Fabrizi, F., Messa, P. G., Lunghi, G., Aucella, F., Bisegna, S., Mangano, S., Villa, M., Barbisoni, F., Rusconi, E., & Martin, P. (2005). Occult hepatitis B virus infection in dialysis patients: A multicentre survey. Alimentary Pharmacology and Therapeutics, 21(11), 1341-1347. https://doi.org/10.1111/j.1365-2036.2005.02501.x